WiCap® is a low-flow, sidestream wireless capnography device designed for instantaneous and continuous monitoring of expired (EtCO2), inspired (FiCO2) breath, respiration rate (RR), SpO2, and pulse rate (PR) measurements.

Continuous waveform capnography is recommended in addition to clinical assessment as the most reliable method of confirming and monitoring correct placement of an endotracheal tube.1

The WiCap patient monitor can use either the provided medical grade AC power supply or use the internal rechargeable Lithium-Polymer battery. A large color touch screen display shows numeric values and waveforms of measured parameters.

Nearly 5 million Americans are currently living with Congestive Heart Failure (CHF)2. Approximately 550,000 new cases are diagnosed in the U.S. each year3. Changes in the ventilatory and circulatory status of the CHF patient will affect CO2 levels sooner than changes in the oxygen saturation.

Chronic Obstructive Pulmonary Disease (COPD) affects over 24 million people4. The etCO2 waveform and values, as part of the comprehensive WiCap suite, is a tool for the provider to diagnose and treat a patient and the causes. Waveform capnography is essential in assessing the severity of bronchospasm in asthma and COPD patients.

1AHA Standards, (2010). 2American Heart Association (2013). 3Heart Failure Society of America. 4COPD Foundation (2013).

FDA cleared.


  • All patient information color-coded according to user-set parameters
  • Large, highly-visible color touch-screen interface
  • Oversized icons are easy-to-read and use with gloves